Explore
Trendline
Advanced NanoTherapies Secures $31M Series B Funding for Innovative Vascular Treatment
Advanced NanoTherapies Secures $31M Series B Funding for Innovative Vascular Treatment
Read More
Trendline
Advanced NanoTherapies Secures $31M Series B Funding for Innovative Vascular Treatment Platform
Advanced NanoTherapies Secures $31M Series B Funding for Innovative Vascular Treatment Platform
Read More
Trendline
Moonlight Therapeutics Launches Phase I Trial for Peanut Allergy Treatment MOON101
Moonlight Therapeutics Launches Phase I Trial for Peanut Allergy Treatment MOON101
Read More
AP News
Swiss forward Embolo goes to US embassy for urgent World Cup visa after travel denied
Switzerland forward Breel Embolo has applied for an urgent visa at the United States embassy in Bern one day after he was denied boarding the team’s flight to the World Cup
Read More
Trendline
Bluejay Diagnostics Partners with Argonaut to Enhance U.S. Manufacturing for Critical-Care Tests
Bluejay Diagnostics Partners with Argonaut to Enhance U.S. Manufacturing for Critical-Care Tests
Read More
Trendline
Insulet Corporation Enhances Omnipod 5 Algorithm, Expands Sensor Compatibility in U.S.
Insulet Corporation Enhances Omnipod 5 Algorithm, Expands Sensor Compatibility in U.S.
Read More
SB Nation
Kyle Shanahan believes 49ers rookie RB can become asset in the passing game
How will Kaelon Black get on the field in Year 1?
Read More
Trendline
Xenix Medical Secures FDA Clearance for Riva Posterior Fixation System, Launches Commercially
Xenix Medical Secures FDA Clearance for Riva Posterior Fixation System, Launches Commercially
Read More
AP News
Nvidia bets on AI personal computers with new 'superchip' powering Windows laptops
Nvidia has unveiled powerful new chips to bring advanced artificial intelligence to Windows laptops and desktops
Read More
Trendline
Cristian Volpato Switches Eligibility to Join Australia's World Cup Roster
Cristian Volpato Switches Eligibility to Join Australia's World Cup Roster
Read More
Trendline
Decoy Therapeutics and hVIVO Collaborate to Advance Antiviral Drug Development
Decoy Therapeutics and hVIVO Collaborate to Advance Antiviral Drug Development
Read More
Trendline
Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials
Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials
Read More